Medical Journals

Role of Scavenger Receptor Class B Type I and Sphingosine 1-phosphate Receptors in High Density Lipoprotein-induced Inhibition of Adhesion Molecule Expression in Endothelial Cells.

Authors:
  • Kimura Takao
  • Tomura Hideaki
  • Mogi Chihiro
  • Kuwabara Atsushi
  • Damirin Alatangaole
  • Ishizuka Tamotsu
  • Sekiguchi Akihiro
  • Ishiwara Mitsuteru
  • Im Doon-Soon
  • Sato Koichi
  • Murakami Masami
  • Okajima Fumikazu

From: Laboratory of Signal Transduction, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8512, Japan.

The Journal of biological chemistry

  • Publish Date: Dec 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 49
  • Pages: 37457-67
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kimura Takao, Tomura Hideaki, Mogi Chihiro, et al. Role of Scavenger Receptor Class B Type I and Sphingosine 1-phosphate Receptors in High Density Lipoprotein-induced Inhibition of Adhesion Molecule Expression in Endothelial Cells.. J. Biol. Chem. Dec 2006;281:37457-67

Abstract

We characterized the molecular mechanisms by which high density lipoprotein (HDL) inhibits the expression of adhesion molecules, including vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, induced by sphingosine 1-phosphate (S1P) and tumor necrosis factor (TNF) alpha in endothelial cells. HDL inhibited S1P-induced nuclear factor kappaB activation and adhesion molecule expression in human umbilical vein endothelial cells. The inhibitory HDL actions were associated with nitric-oxide synthase (NOS) activation and were reversed by inhibitors for phosphatidylinositol 3-kinase and NOS. The HDL-induced inhibitory actions were also attenuated by the down-regulation of scavenger receptor class B type I (SR-BI) and its associated protein PDZK1. When TNFalpha was used as a stimulant, the HDL-induced NOS activation and the inhibitory action on adhesion molecule expression were, in part, attenuated by the down-regulation of the expression of S1P receptors, especially S1P(1), in addition to SR-BI. Reconstituted HDL composed mainly of apolipoprotein A-I and phosphatidylcholine mimicked the SR-BI-sensitive part of HDL-induced actions. Down-regulation of S1P(3) receptors severely suppressed the stimulatory actions of S1P. Although G(i/o) proteins may play roles in either stimulatory or inhibitory S1P actions, as judged from pertussis toxin sensitivity, the coupling of S1P(3) receptors to G(12/13) proteins may be critical to distinguish the stimulatory pathways from the inhibitory ones. In conclusion, even though S1P alone stimulates adhesion molecule expression, HDL overcomes S1P(3) receptor-mediated stimulatory actions through SR-BI/PDZK1-mediated signaling pathways involving phosphatidylinositol 3-kinase and NOS. In addition, the S1P component of HDL plays a role in the inhibition of TNFalpha-induced actions through S1P receptors, especially S1P(1).

Mesh Headings (Keywords): Cell Adhesion Molecules, Cells, Cultured, Endothelial Cells, Enzyme Activation, Humans, Intercellular Adhesion Molecule-1, Lipoproteins, HDL, Models, Biological, Nitric Oxide Synthase Type III, Receptors, Lysosphingolipid, Scavenger Receptors, Class B, Signal Transduction, Vascular Cell Adhesion Molecule-1


Check for Full Text / PubMed Unique Identifier (PMID): 17046831


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.